Cholinesterase inhibitors (ChEIs), also known as acetylcholinesterase inhibitors, are medications usually prescribed to treat symptoms of Alzheimer’s disease. However, they can also be used to treat other conditions, such as Parkinson’s disease. These medications help increase levels of acetylcholine, an important neurotransmitter in the body needed for communication between nerve cells, and they are only available with a prescription.
Continue reading to learn more about cholinesterase inhibitors, how they work, and their possible side effects.
Drug name | Learn more | See SingleCare price |
---|---|---|
Aricept | aricept details | aricept price |
Donepezil Hcl | donepezil-hcl details | donepezil-hcl price |
Razadyne | razadyne details | razadyne price |
Galantamine Hydrobromide | galantamine-hydrobromide details | galantamine-hydrobromide price |
Exelon | exelon details | exelon price |
Rivastigmine | rivastigmine details | rivastigmine price |
Namzaric | namzaric details | namzaric price |
Mestinon | mestinon details | mestinon price |
Pyridostigmine Bromide | pyridostigmine-bromide details | pyridostigmine-bromide price |
Cognex (tacrine)
Bloxiverz (neostigmine)
Humorsol (demecarium)
Enlon (edrophonium)
Mytelase (ambenonium)
Metrifonate
Phenserine
Cholinesterase inhibitors are medications used to treat neurodegenerative conditions, such as Alzheimer’s disease and Parkinson’s disease. They are primarily used to treat symptoms of dementia and other signs of cognitive impairment in people with Alzheimer’s disease. Those with dementia often show a decline in cognition, which is characterized by frequent instances of memory loss, confusion, trouble with communication, or problems with organization.
The three main cholinesterase inhibitors prescribed for Alzheimer’s disease are Aricept (donepezil), Razadyne ER (galantamine), and Exelon (rivastigmine). Depending on the severity of the disease, clinicians may add Namenda (memantine) to the treatment regimen.
Cholinesterase inhibitors come in several different formulations depending on the medication prescribed. Cholinesterase inhibitors are available as medications that can be administered orally, intravenously (IV), intramuscularly (IM), or transdermally (as a patch). Oral forms of cholinesterase inhibitors are usually administered once or twice a day, depending on which medication is prescribed.
Acetylcholine is a primary neurotransmitter, or nerve signal messenger, found at cholinergic receptor sites in the peripheral and central nervous system (CNS). It is involved with many important functions, such as smooth muscle contractions, regulation of blood pressure and heart rate, and the processing of memories and information. While the exact cause of Alzheimer’s disease is unclear, those with Alzheimer’s disease typically have low levels of acetylcholine, which may contribute to symptoms.
As the name suggests, cholinesterase inhibitors work by blocking cholinesterase, an enzyme that breaks down acetylcholine or butyrylcholine. Sometimes known as anticholinesterases, these medications help prevent the breakdown of acetylcholine and increase the amount of acetylcholine available in the body. One meta-analysis compared the effectiveness and tolerability of cholinesterase inhibitors in 41 different clinical trials published by The Lancet and The BMJ, among other journals. Results from this meta-analysis showed that these medications can help improve cognitive function in those with Alzheimer’s disease.
Cholinesterase inhibitors can be used for different purposes other than the treatment of Alzheimer’s disease. They’re often prescribed for a range of different medical uses:
Vascular dementia
Lewy body dementia
Alzheimer’s disease
Parkinson’s disease
Vascular dementia
Muscle agent effects reversal after surgery
Anticholinergic drug toxicity
Acetylcholinesterase is one of two types of cholinesterase enzymes, and it is the primary target of treatment for Alzheimer’s disease. Most cholinesterase inhibitors can block both acetylcholinesterase and butyrylcholinesterase, but some may be more selective for acetylcholinesterase than others. Aricept (donepezil) and Razadyne (galantamine) are examples of selective acetylcholinesterase inhibitors.
Butyrylcholinesterase is a cholinesterase enzyme that may be increased in severe Alzheimer’s disease. Cognex (tacrine) is an example of a cholinesterase inhibitor that can block both the acetylcholinesterase and butyrylcholinesterase enzyme. However, it has more selectivity for butyrylcholinesterase.
Cholinesterase inhibitors can be further classified as competitive, non-competitive, irreversible, or pseudo-irreversible inhibitors. These categories of cholinesterase inhibitors refer to how strongly the drug binds to the active site of the cholinesterase enzyme to block it. Donepezil is a mixed competitive and non-competitive inhibitor, galantamine is a competitive inhibitor, organophosphates like sarin and methanesulfonyl fluoride are irreversible inhibitors, and rivastigmine and metrifonate are pseudo-irreversible inhibitors.
Adult men and women with dementia disorders are often prescribed a cholinesterase inhibitor. Compared to placebo, cholinesterase inhibitors are considered effective in most adults. They are sometimes given with other forms of treatment to treat different neurodegenerative conditions in adults.
As noted in prevalence studies from the Alzheimer’s Association, Alzheimer’s disease is a condition that primarily affects older adults. As a result, cholinesterase inhibitors are often prescribed in older adults to treat dementia. The average age of people enrolled in clinical trials evaluating the use of Aricept is 73. Still, caregivers should monitor older adults for possible adverse effects from cholinesterase inhibitors.
The American Geriatrics Society recommends regular follow-up visits for older adults who use cholinesterase inhibitors in order to evaluate how well the medication is working and to identify any adverse effects.
Cholinesterase inhibitors are not approved by the Food and Drug Administration (FDA) or recommended for use in children. However, in some situations, cholinesterase inhibitors may be prescribed off-label for different purposes. Clinical studies have found that certain cholinesterase inhibitors may be useful for alleviating symptoms in children with ADHD and improving REM sleep in children with autism.
Cholinesterase inhibitors are generally safe and effective, according to clinical controlled trials. However, the use of cholinesterase inhibitors can lead to high levels of acetylcholine. These medications can cause side effects involving the parasympathetic nervous system, such as stomach upset, increased salivation and tearing, increased urination, slow heartbeat, diarrhea, and low blood pressure.
No current recalls are available.
Those with heart conduction diseases or low heart rate may need to avoid cholinesterase inhibitors. These medications can increase the risk of low heart rate and heart conduction problems, which could lead to an increased risk of fainting or falls. Patients with low blood pressure, or hypotension, may also need to avoid cholinesterase inhibitors due to an increased risk of low blood pressure.
Patients with stomach ulcers or those taking nonsteroidal anti-inflammatory drugs (NSAIDs) should avoid cholinesterase inhibitors because of an increased risk of bleeding with cholinesterase inhibitors. Those with urinary retention problems should also avoid taking cholinesterase inhibitors since these drugs can cause urinary incontinence as a side effect.
Symptoms of asthma and chronic obstructive pulmonary disease (COPD) may be worsened with the use of cholinesterase inhibitors. These medications can increase acetylcholine, which plays a role in bronchial secretions and constriction of the bronchial tubes.
Cholinesterase inhibitors can increase the risk of seizures in certain individuals. Patients with a history of seizures may need to use caution while taking a cholinesterase inhibitor.
Cholinesterase inhibitors should not be used in those with a history of allergic reactions to any cholinesterase inhibitor in the past.
Consult your prescribing healthcare provider for other possible warnings and restrictions before starting treatment with a cholinesterase inhibitor. A doctor who specializes in neurology or pharmacology can help determine whether a cholinesterase inhibitor would be appropriate for you.
No, cholinesterase inhibitors are not controlled substances.
The most common side effects of cholinesterase inhibitors include:
Nausea
Vomiting
Diarrhea
Dizziness
Cramps
Headache
Fatigue
Insomnia
Abnormal dreams
Decreased appetite
Weight loss
Increased urination
Most cholinesterase inhibitors are generally well tolerated with mild side effects. Side effects may be lessened through the use of different dosing techniques, such as lowering the dose of the medication (with a doctor’s approval) or administering the medication with meals. The timing of drug administration may also influence the development of side effects. Taking donepezil in the morning instead of at night may decrease the risk of abnormal dreams.
Severe side effects and adverse events typically develop as a result of toxicity, or taking doses that are higher than normal. Serious side effects can include severe nausea and vomiting, gastrointestinal bleeding, and respiratory depression. Involuntary muscle movements or paralysis are other signs of toxicity. Immediate medical attention is necessary to reverse the effects of toxicity from cholinesterase inhibitors.
Adverse effects may also occur as a result of drug interactions. Consult a healthcare provider to determine thge risk of drug interactions, depending on other drugs you may be taking. Tell your doctor if you’re taking other medications that have cholinergic or anticholinergic effects. You should also tell your doctor about any prescription medications, over-the-counter medications, and herbal supplements you may be taking.
Cholinesterase inhibitors are generally covered by most Medicare and insurance plans. These medications are typically available in both a brand name and generic version, the latter of which is often the cheaper alternative. The total cost for your cholinesterase inhibitor prescription will depend on the drug and dosage prescribed, as well as the quantity supplied.
For those without insurance, other savings options such as manufacturer coupons and patient assistance programs may be available to lower the cost of cholinesterase inhibitors. SingleCare also provides a prescription discount savings card that may reduce the cost of cholinesterase inhibitors, or other prescription medications, whether you’re insured or uninsured.
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...(Except Major Holidays)
© 2024 SingleCare Administrators. All Rights Reserved.
* Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
This is a prescription discount plan. This is NOT insurance nor a Medicare prescription drug plan. The range of prescription discounts provided under this discount plan will vary depending on the prescription and pharmacy where the prescription is purchased and can be up to 80% off the cash price. You are fully responsible for paying your prescriptions at the pharmacy at the time of service, but you will be entitled to receive a discount from the pharmacy in accordance with the specific pre-negotiated discounted rate schedule. Towers Administrators LLC (operating as 'SingleCare Administrators') is the authorized prescription discount plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services LLC ('SingleCare') is the vendor of the prescription discount plan, including their website.website at www.singlecare.com. For additional information, including an up-to-date list of pharmacies, or assistance with any problems related to this prescription drug discount plan, please contact customer service toll free at 844-234-3057, 24 hours a day, 7 days a week (except major holidays). By using the SingleCare prescription discount card or app, you agree to the SingleCare Terms and Conditions found at https://www.singlecare.com/terms-and-conditions